|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| (11) | Number of the document | 2663577 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12700433.1 |
| Date of filing the European patent application | 2012-01-11 | |
| (97) | Date of publication of the European application | 2013-11-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-12 |
| (46) | Date of publication of the claims translation | 2017-07-25 |
| (86) | Number | PCT/GB2012/050050 |
| Date | 2012-01-11 |
| (87) | Number | WO 2012/095662 |
| Date | 2012-07-19 |
| (30) | Number | Date | Country code |
| 201161432814 P | 2011-01-14 | US |
| (72) |
ADAMS, Ralph, GB
BAKER, Terence Seward, GB
LAWSON, Alastair David Griffiths, GB
|
| (73) |
UCB Biopharma SRL,
Alée de la Recherche 60, 1070 Brussels,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnas, surišantis IL-17A ir IL-17F |
| ANTIBODY BINDING IL-17A AND IL-17F |
| Payment date | Validity (years) | Amount | |
| 2024-12-03 | 14 | 289.00 EUR |
| 2026-01-11 |